Digital Poster Exhibition
65th Annual Meeting Society of Thrombosis and Hemostasis Research
65th Annual Meeting Society of Thrombosis and Hemostasis Research
A bedside urine based test strip on identifying anticoagulation with direct oral anticoagulants at a high-volume emergency department – a diagnostic test accuracy study
Abnormal urine is detected by a specific pad of DOAC Dipstick near patient test strip
Accuracy of the STA®-Liquid anti-Xa assay in clinical practice: results from a large cross-sectional study in Switzerland
A comparison of prophylaxis dosing frequency and associated clinical outcomes between rVIII-SingleChain and other rFVIII products commonly used in Italian patients with haemophilia A
Acquired von Willebrand syndrome associated with monoclonal gammopathy of undetermined significance – successful treatment with lenalidomide and dexamethasone
A matching‐adjusted indirect comparison in patients with severe haemophilia A: Comparing the efficacy and consumption of rVIII-SingleChain vs two recombinant FVIII
Analysis of adherence to therapy comparing DOAC Dipstick test with plasma concentration of rivaroxaban and apixaban in outpatients with venous thromboembolic disease
An analysis of fatalities in persons with congenital hemophilia A (PwcHA) reported in the FDA Adverse Event Reporting System (FAERS) database
Annual bleeding rate and factor consumption – comparison between extended and short half-life factor VIII in real life according to electronic documentation smart medication
A Phase II study to investigate the efficacy and safety of eltrombopag in combination with dexamethasone as first-line treatment in adult patients with newly diagnosed primary ITP (XPAG-ITP)
A retrospective patient chart review of real-world clinical outcomes and prophylactic factor VIII consumption in Italian patients with haemophilia A switching to extended dosing intervals with rVIII SingleChain
Cancer cell-derived microparticles expressing tissue factor have pivotal role on the procoagulant shift of endothelial cells
Case report: Use of recombinant von Willebrand factor in a patient with acquired von Willebrand syndrome due to specific IgM-antibodies directed against vWF
Causes of Acquired von Willebrands Disease Type II in Pediatric Patients. Cases and literature review.
Changes in Vascular Physiology in Patients with ESRD Compared to Patients with ESRD and Concomitant Cardiovascular Disorder
Characterization of rFIX fusion proteins enabling subcutaneous administration
Clinical usefulness of the novel DOAC Dipstick near patient test strip in emergency settings using semi-automatic DOASENSE Reader
Comparing automated FXIII assays
Cooperation of platelet beta1 and beta3 integrins in the arrest of inflammatory bleeding in mice
Detection thrombogenicity antiphospolipid antibodies with APC modified TGT
Development of annual joint bleeds and factor consumption during the last 6 years in 14 haemophilia centers - real life data from electronic documentation smart medication
Differences in venous thromboembolism prophylaxis between gastroenterology and cardiology inpatients.
Efficacy of direct oral anticoagulants in plasma from patients with liver cirrhosis at high thrombotic risk
Evaluation of different processing methods to label platelets for in vivo studies
Evaluation of thrombin generation in patients with sickle cell disease in stable disease and sickle cell crises
Evolution of platelet phenotype during SARS-CoV-2 infection
Examination of the Rac-modulator ArhGAP15 in platelet activation.
Factors influencing bleeding severity in adult patients with primary immune thrombocytopenia
Functional assays to unravell the pathogenetic role of variants found in GFI1B in piastrinopenic patients
GATA1 pathogenic variants disrupt MYH10 silencing during megakaryopoiesis
Hepatic Disorders Contribute to Platelet Dysfunction
Impact of DOAC Dipstick test and relation to plasma and urine concentrations to exclude the presence of clinically relevant concentrations of DOACs in real-life patient setting – study protocol and case reports
Increased soluble thrombomodulin influences fibrin clot formation in patients with mild to moderate bleeding tendency
Insight into the role of miR-223-3p in regulating platelet reactivity
Interaction of direct oral anticoagulants and other anticoagulants on DOAC Dipstick test
International Myeloma Working Group ( IMWG) score accuracy in multiple myeloma patients: need for action.
In vitro characterization of K5A and K5R variants of Factor IX
Joint bleeds and pain related treatment – comparison of data between 2017 and 2019 according to electronic diary smart-medication
Laboratory phenotype variability in genetically proven von Willebrand disease type 2B
Long-term efficacy and safety of rIX-FP prophylaxis in adult patients with haemophilia B on a 21-day dosing regimen
Monitoring pain and joint health in patients with haemophilia
Newly diagnosed children and adolescents with haemophilia A and B in Germany – the GEPHARD study of the `Standing Commission Paediatrics of the Society for Thrombosis and Haemostasis Research
Non-criteria antiphospholipid antibodies anti-PT/PS, anti-Anexin V: benefit in diagnostics of antiphospholipid syndrome?
Noonon syndrome as unlikely cause of increased bruising in a case of suspected battered child syndrome
Performance evaluation of the BIOPHEN chromogenic test for Factor XIII activity on the Cobas c502 System
Prolonged chemotherapeutic stress is accompanied by an aggressive and singular vascularization process with a high thrombogenic potential in Colorectal Cancer
Quantification of Bovine and Porcine Heparin Red Assay Utilizing the Heparin Red Assay. Applications in the Study of Pharmacokinetics and Pharmacodynamics.
Real-world experience on the use of rIX-FP in patients with haemophilia B: Interim results from a prospective, non-interventional, post-market surveillance study in Germany
Reelin supports Glycoprotein VI and integrin outside-in signaling of platelets
Retrospective analysis of persons after mild COVID-19 in the context of a convalescent plasma donation
Reversal of DOAC in RVV-test on the ClotPro analyzer
Sheep Mucosal Heparin as a Substitute for Porcine Mucosal Heparin. A Viable Option to Address the Potential Shortage Crisis.
smart medication DocuScan: GSAV-compliant documentation of hemophilia preparations for pharmacies, doctors, treatment centers and patients
Sulodexide as a Parenteral Anticoagulant. A Substitute for Unfractionated Heparin.
The occurrence of trombocythopathy in CLL patients treated with Ibrutinib
The role of platelet mitochondrial function for platelet mediated Aβ40 aggregation
Thrombophilic Phaenotype in a Family with High Frequency of Homozygous Antithrombin Deficiency Typ IIb Budapest 3 and Mild Factor VII Deficiency due to Homozygous Polymorphisms in the Factor 7 Gene and Antithrombotic Treatment
Thrombopoietin levels in sepsis and septic shock - a meta-analysis.
Treatment of acquired thrombotic thrombocytopenic without plasma exchange in selected patients under caplacizumab
Type 2B von Willebrand disease – a rare cause of neonatal thrombocytopenia
Usefulness of global assays to monitor treatment of a patient with Hemophilia A switching from factor to non-factor replacement therapy
Whole blood anticoagulant effects of Sulodexide as measured by activated clotting time and their neutralization by Protamine sulfate